封面
市場調查報告書
商品編碼
1966131

全球伴侶動物診斷市場規模、佔有率、趨勢和成長分析報告(2026-2034)

Global Companion Animal Diagnostic Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 168 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年,伴侶動物診斷市場規模將從 2025 年的 70.7 億美元成長至 160.4 億美元,2026 年至 2034 年的複合年成長率為 9.52%。

隨著全球寵物飼養量的成長以及寵物擬人化趨勢的日益盛行,伴侶動物診斷市場正蓬勃發展。獸醫醫院擴大使用先進的診斷工具,例如血液分析儀、免疫檢測、分子診斷和成像系統,以實現疾病的早期發現並改善治療效果。預防醫學意識的提高也推動了對定期篩檢的需求。

寵物醫療保健成本不斷上漲、就地檢驗進步以及快速診斷試劑盒的廣泛應用是推動寵物醫療成長要素。攜帶式分析儀和遠距獸醫服務的技術創新正在提高寵物醫療服務的可及性和效率。通用感染疾病和寵物慢性病發病率的上升進一步推動了對寵物診斷的需求。

未來前景強勁,主要得益於寵物保險普及率的提高以及新興市場伴侶動物飼養量的成長。人工智慧輔助診斷平台和基因組檢測技術的發展有望改變獸醫學。儘管部分地區存在成本方面的擔憂,但持續的技術創新以及飼主與其寵物之間深厚的情感紐帶預計將支撐市場健康成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球伴侶動物診斷市場:依動物類型分類

  • 市場分析、洞察與預測
  • 其他伴侶動物

第5章:全球伴侶動物診斷市場:依技術分類

  • 市場分析、洞察與預測
  • 臨床生物化學
  • 免疫診斷
  • 血液學
  • 分子診斷
  • 尿液檢查
  • 其他

第6章 全球伴侶動物診斷市場:依應用領域分類

  • 市場分析、洞察與預測
  • 臨床病理
  • 細菌學
  • 病毒學
  • 寄生蟲學
  • 其他

第7章 全球伴侶動物診斷市場:依最終用途分類

  • 市場分析、洞察與預測
  • 診斷檢查室
  • 獸醫醫院和診所
  • 即時檢測/院內檢測
  • 研究機構和大學

第8章:全球伴侶動物診斷市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zoetis
    • BiomAfA(C)Rieux
    • Heska Corporation
    • Idexx Laboratories Inc
    • Idvet
    • Neogen Corporation
    • Qiagen
    • Randox Laboratories Ltd
    • Thermo Fisher Scientific Inc
    • Virbac
簡介目錄
Product Code: VMR11210437

The Companion Animal Diagnostic Market size is expected to reach USD 16.04 Billion in 2034 from USD 7.07 Billion (2025) growing at a CAGR of 9.52% during 2026-2034.

The companion animal diagnostic market has expanded significantly as pet ownership and pet humanization trends rise worldwide. Veterinary clinics increasingly utilize advanced diagnostic tools such as hematology analyzers, immunoassays, molecular diagnostics, and imaging systems to detect diseases early and improve treatment outcomes. Growth in preventive care awareness has also boosted routine screening demand.

Key drivers include higher spending on pet healthcare, advancements in point-of-care testing, and the availability of rapid diagnostic kits. Technological innovation in portable analyzers and tele-veterinary services enhances accessibility and efficiency. Increasing incidence of zoonotic and chronic diseases in pets further fuels diagnostic demand.

Future prospects are strong as pet insurance penetration increases and emerging markets witness rising adoption of companion animals. Development of AI-assisted diagnostic platforms and genomic testing may reshape veterinary care. Despite cost sensitivity in some regions, the market is expected to sustain healthy growth supported by ongoing innovation and emotional attachment between owners and pets.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal

  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

By Technology

  • Clinical Biochemistry
  • Immunodiagnostics
  • Hematology
  • Molecular Diagnostics
  • Urinalysis
  • Others

By Application

  • Clinical Pathology
  • Bacteriology
  • Virology
  • Parasitology
  • Others

By End Use

  • Diagnostic Laboratories
  • Veterinary Hospitals And Clinics
  • Point-Of-Care/In-House Testing
  • Research Institutes And Universities

COMPANIES PROFILED

  • Zoetis, Biomrieux, Heska Corporation, Idexx Laboratories Inc, Idvet, Neogen Corporation, Qiagen, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY ANIMAL 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Animal
  • 4.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Horses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Other Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Clinical Biochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Immunodiagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Urinalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Clinical Pathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Bacteriology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Virology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Parasitology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Veterinary Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Point-Of-Care/In-House Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Research Institutes And Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Animal
    • 8.2.2 By Technology
    • 8.2.3 By Application
    • 8.2.4 By End Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Animal
    • 8.3.2 By Technology
    • 8.3.3 By Application
    • 8.3.4 By End Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Animal
    • 8.4.2 By Technology
    • 8.4.3 By Application
    • 8.4.4 By End Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Animal
    • 8.5.2 By Technology
    • 8.5.3 By Application
    • 8.5.4 By End Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Animal
    • 8.6.2 By Technology
    • 8.6.3 By Application
    • 8.6.4 By End Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL DIAGNOSTIC INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Zoetis
    • 10.2.2 BiomAfA(C)Rieux
    • 10.2.3 Heska Corporation
    • 10.2.4 Idexx Laboratories Inc
    • 10.2.5 Idvet
    • 10.2.6 Neogen Corporation
    • 10.2.7 Qiagen
    • 10.2.8 Randox Laboratories Ltd
    • 10.2.9 Thermo Fisher Scientific Inc
    • 10.2.10 Virbac